MARK LUPHER
Profile
First Name
: MARK
Middle Name
:
Last Name
: LUPHER
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
JAMES W BRODERICK, JAMES W. BRODERICK, JAMES W. BRODERICK, M.D., DOMINICK C COLANGELO, DOMINICK C. COLANGELO, JOHN FRIEDMAN, JOHN H. FRIEDMAN, PAUL D GOLDENHEIM, PAUL D. GOLDENHEIM, PAUL D. GOLDENHEIM, M.D., LARRY KAUVAR, GEERT-JAN MULDER, AMIR NASHAT, HANNS A. PIELENZ, HAROLD R WERNER, HAROLD R. WERNER, JOSEPH ZAKRZEWSKI, JOSEPH S. ZAKRZEWSKI
DIRECTOR
LINDA BAIN, MARK BLUMENKRANZ, MARK S. BLUMENKRANZ, THOMAS CHALBERG, THOMAS W. CHALBERG, LAURENT FISCHER, MEHDI GASMI, SOO HONG, HANS HULL, PATRICK MACHADO, JOHN MCLAUGHLIN, C. DAVID NICHOLSON, RABIA GURSES OZDEN, LINDA RUBINSTEIN, STEVEN SCHWARTZ, STEVEN D. SCHWARTZ, STEVEN D. SCHWARZ, JAMES SCOPA, SETAREH SEYEDKAZEMI, KISHOR PETER SOPARKAR, DAWN SVORONOS, REED TUCKSON, PAUL WACHTER, PAUL D. WACHTER, SCOTT WHITCUP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2024-02-07
